![IHC-P analysis of human testis tissue using GTX04425 ACE2 antibody [MSVA-919R] HistoMAX?.<br>Leydig cells and spermatocytes of the testis show a particularly strong ACE2 immunostaining in the testis.](/domestic/data/graphics/GNT/graphics/GTX04425_20230728_IHC-P_2_23072722_840_s.jpg)
IHC-P analysis of human testis tissue using GTX04425 ACE2 antibody [MSVA-919R] HistoMAX?.
Leydig cells and spermatocytes of the testis show a particularly strong ACE2 immunostaining in the testis.
![IHC-P analysis of human clear cell renal cell carcinoma (ccRCC) tissue using GTX04425 ACE2 antibody [MSVA-919R] HistoMAX?.<br>Clear cell renal cell carcinoma strong strong membraous ACE2 positivity.](/domestic/data/graphics/GNT/graphics/GTX04425_20230728_IHC-P_262_23072723_389_s.jpg)
IHC-P analysis of human clear cell renal cell carcinoma (ccRCC) tissue using GTX04425 ACE2 antibody [MSVA-919R] HistoMAX?.
Clear cell renal cell carcinoma strong strong membraous ACE2 positivity.
![IHC-P analysis of human renal cortex tissue using GTX04425 ACE2 antibody [MSVA-919R] HistoMAX?.<br>A strong ACE2 immunostaining occurs in proximal tubuli of the kidney.](/domestic/data/graphics/GNT/graphics/GTX04425_20230728_IHC-P_132_23072722_440_s.jpg)
IHC-P analysis of human renal cortex tissue using GTX04425 ACE2 antibody [MSVA-919R] HistoMAX?.
A strong ACE2 immunostaining occurs in proximal tubuli of the kidney.